Hangzhou Tigermed Consulting (3347.HK/300347.CH) - The Business Model May Not Be a Safe Play

Tigermed’s high growth and high valuation are inseparable from continuous M&As and investment. However, uncertain macro environment and risk of recession question if  "CRO+PE/VC" model is a safe play.

  • Despite solid growth in 2021, if seen from prior years, the revenue YoY growth rate and net profit YoY growth rate showed a state of divergence, which is “interesting”.
  • Since half of Tigermed’s net profits were from investment income,it’s not logical to apply the valuation methods of traditional CXO to Tigermed. Its CRO and investment should be valued separately.
  • The poor IPO sentiment, risk of recession and the domestic healthcare rational return would make investors reconsider if Tigermed’s “CRO + PE/VC business model” would be a safe play.

By Xinyao (Criss) Wang - https://www.smartkarma.com/profiles/xinyao-criss-wang?utm_source=tiger_community

On Hangzhou Tigermed Consulting (H) (3347 HK) - https://www.smartkarma.com/entities/hangzhou-tigermed-consulting-co-ltd-1008d609-73bd-4d76-8315-b29502a448ff?utm_source=tiger_community

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
  • Donald TH
    ·2022-04-25
    Nice
    Reply
    Report
  • MoonJin
    ·2022-04-25
    Nice to note
    Reply
    Report
  • haoffee
    ·2022-04-25
    A
    Reply
    Report
  • eldert
    ·2022-04-25
    great
    Reply
    Report
  • KiRa
    ·2022-04-25
    [smile]
    Reply
    Report
  • haoffee
    ·2022-04-25
    A
    Reply
    Report
  • smallred
    ·2022-04-25
    [Salute]
    Reply
    Report
  • Successful
    ·2022-04-25
    Yes
    Reply
    Report
  • 钱来多多
    ·2022-04-25
    K
    Reply
    Report
  • Markiey
    ·2022-04-25
    Oo
    Reply
    Report
  • T20211126001
    ·2022-04-25
    Yed
    Reply
    Report
  • ShayneGun
    ·2022-04-25
    👍
    Reply
    Report
  • hynne
    ·2022-04-25
    o
    Reply
    Report
  • phoebe0824
    ·2022-04-25
    ok
    Reply
    Report
  • bengkoon
    ·2022-04-25
    👍 go od
    Reply
    Report
  • SYCher
    ·2022-04-25
    Noted
    Reply
    Report
  • SFLIM
    ·2022-04-25
    ok
    Reply
    Report
    Fold Replies
    • DarkFate
      Like and good read
      2022-04-25
      Reply
      Report
  • haoffee
    ·2022-04-25
    A
    Reply
    Report
  • Raj16
    ·2022-04-25
    k
    Reply
    Report
  • Rusty11
    ·2022-04-25
    nice
    Reply
    Report